MEDANTA vs SHALBY: Stock Comparison
GLOBAL HEALTH is the larger company by market capitalisation. GLOBAL HEALTH shows a higher ROE, a higher dividend yield and faster revenue growth, while SHALBY shows a lower P/E and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
MEDANTA leads 9; SHALBY leads 4 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | MEDANTA | SHALBY |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Hospital | Hospital |
Price
| Metric | MEDANTA | SHALBY |
|---|---|---|
| Live Price | ₹1,447.2 | ₹144.78 |
| Day Change | -0.85% | -0.81% |
| Volume | 74,678 | 1.13 L |
| 52-Week High | ₹1,544 | ₹274.7 |
| 52-Week Low | ₹956 | ₹125.82 |
| Distance from 52W High | -6.27% | -47.3% |
Valuation
| Metric | MEDANTA | SHALBY |
|---|---|---|
| Market Cap | ₹38,774 Cr | ₹1,557 Cr |
| P/E Ratio | 69.7x | 40.03x |
| P/B Ratio | 9.78x | 1.57x |
| EPS | ₹5.9 | ₹1 |
| Book Value | ₹148.18 | ₹93.11 |
| Dividend Yield | 0.03% | 0% |
Growth
| Metric | MEDANTA | SHALBY |
|---|---|---|
| Revenue Growth (TTM YoY) | 24.5% | 8.5% |
| EPS Growth (TTM YoY) | 42% | 0% |
| Qtr Sales Growth | 20.89% | 30.51% |
| Qtr Profit Growth | 14.53% | -58.13% |
Profitability & Leverage
| Metric | MEDANTA | SHALBY |
|---|---|---|
| ROE | 12.37% | 9.06% |
| ROCE | 11.4% | 9.26% |
| Net Margin | 12.62% | 3.28% |
| Operating Margin | 18.62% | 14.33% |
| Debt to Equity | 0.17x | 0.1x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | MEDANTA | SHALBY |
|---|---|---|
| Promoter Holding | 33%▼ 0.01 pp | 74.33% |
| FII Holding | 9.46%▼ 0.69 pp | 4.46%▲ 0.1 pp |
| DII Holding | 16.89%▲ 2.13 pp | 0.3%▲ 0.05 pp |
| Public Holding | 40.56%▼ 1.44 pp | 20.26%▼ 0.15 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: GLOBAL HEALTH and SHALBY.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.